vs
Fulgent Genetics, Inc.(FLGT)与RCI HOSPITALITY HOLDINGS, INC.(RICK)财务数据对比。点击上方公司名可切换其他公司
Fulgent Genetics, Inc.的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.2倍($83.3M vs $70.9M),RCI HOSPITALITY HOLDINGS, INC.净利率更高(-7.8% vs -28.1%,领先20.3%),Fulgent Genetics, Inc.同比增速更快(9.3% vs -3.1%),RCI HOSPITALITY HOLDINGS, INC.自由现金流更多($11.5M vs $-83.1M),过去两年Fulgent Genetics, Inc.的营收复合增速更高(13.7% vs -2.0%)
Fulgent Genetics是一家分子诊断技术企业,开发并提供覆盖携带者筛查、肿瘤基因检测、传染病检测、遗传性疾病分析的多元基因检测服务,主要客户为北美地区的医疗机构、药企、科研院所及公共卫生组织。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅,同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市,目前在纳斯达克全球市场挂牌交易。
FLGT vs RICK — 直观对比
营收规模更大
FLGT
是对方的1.2倍
$70.9M
营收增速更快
FLGT
高出12.5%
-3.1%
净利率更高
RICK
高出20.3%
-28.1%
自由现金流更多
RICK
多$94.6M
$-83.1M
两年增速更快
FLGT
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $83.3M | $70.9M |
| 净利润 | $-23.4M | $-5.5M |
| 毛利率 | 39.1% | — |
| 营业利润率 | -43.5% | -0.7% |
| 净利率 | -28.1% | -7.8% |
| 营收同比 | 9.3% | -3.1% |
| 净利润同比 | -297.7% | -2354.9% |
| 每股收益(稀释后) | — | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FLGT
RICK
| Q4 25 | $83.3M | — | ||
| Q3 25 | $84.1M | $70.9M | ||
| Q2 25 | $81.8M | $71.1M | ||
| Q1 25 | $73.5M | $65.9M | ||
| Q4 24 | $76.2M | $71.5M | ||
| Q3 24 | $71.7M | $73.2M | ||
| Q2 24 | $71.0M | $76.2M | ||
| Q1 24 | $64.5M | $72.3M |
净利润
FLGT
RICK
| Q4 25 | $-23.4M | — | ||
| Q3 25 | $-6.6M | $-5.5M | ||
| Q2 25 | $-19.0M | $4.1M | ||
| Q1 25 | $-11.5M | $3.2M | ||
| Q4 24 | $-5.9M | $9.0M | ||
| Q3 24 | $-14.6M | $244.0K | ||
| Q2 24 | $-8.7M | $-5.2M | ||
| Q1 24 | $-13.5M | $774.0K |
毛利率
FLGT
RICK
| Q4 25 | 39.1% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 42.1% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 37.3% | — | ||
| Q1 24 | 34.3% | — |
营业利润率
FLGT
RICK
| Q4 25 | -43.5% | — | ||
| Q3 25 | -18.3% | -0.7% | ||
| Q2 25 | -24.1% | 12.2% | ||
| Q1 25 | -26.9% | 12.4% | ||
| Q4 24 | -21.2% | 19.5% | ||
| Q3 24 | -23.8% | 4.8% | ||
| Q2 24 | -26.6% | -3.3% | ||
| Q1 24 | -33.8% | 6.4% |
净利率
FLGT
RICK
| Q4 25 | -28.1% | — | ||
| Q3 25 | -7.9% | -7.8% | ||
| Q2 25 | -23.2% | 5.7% | ||
| Q1 25 | -15.7% | 4.9% | ||
| Q4 24 | -7.7% | 12.6% | ||
| Q3 24 | -20.4% | 0.3% | ||
| Q2 24 | -12.3% | -6.9% | ||
| Q1 24 | -20.9% | 1.1% |
每股收益(稀释后)
FLGT
RICK
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.60 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.36 | ||
| Q4 24 | — | $1.01 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $-0.56 | ||
| Q1 24 | — | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $50.2M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $1.1B | $261.1M |
| 总资产 | $1.2B | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势,按日历期对齐
现金及短期投资
FLGT
RICK
| Q4 25 | $50.2M | — | ||
| Q3 25 | $117.6M | $33.7M | ||
| Q2 25 | $87.9M | $29.3M | ||
| Q1 25 | $67.3M | $32.7M | ||
| Q4 24 | $55.1M | $34.7M | ||
| Q3 24 | $58.0M | $32.4M | ||
| Q2 24 | $65.1M | $34.9M | ||
| Q1 24 | $54.7M | $20.0M |
总债务
FLGT
RICK
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
FLGT
RICK
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $261.1M | ||
| Q2 25 | $1.1B | $269.5M | ||
| Q1 25 | $1.1B | $268.8M | ||
| Q4 24 | $1.1B | $269.0M | ||
| Q3 24 | $1.1B | $263.4M | ||
| Q2 24 | $1.1B | $271.2M | ||
| Q1 24 | $1.1B | $285.8M |
总资产
FLGT
RICK
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $596.9M | ||
| Q2 25 | $1.2B | $597.4M | ||
| Q1 25 | $1.2B | $589.8M | ||
| Q4 24 | $1.2B | $586.2M | ||
| Q3 24 | $1.2B | $584.4M | ||
| Q2 24 | $1.2B | $601.0M | ||
| Q1 24 | $1.2B | $609.9M |
负债/权益比
FLGT
RICK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-78.1M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $-83.1M | $11.5M |
| 自由现金流率自由现金流/营收 | -99.7% | 16.2% |
| 资本支出强度资本支出/营收 | 6.0% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-124.2M | $34.9M |
8季度趋势,按日历期对齐
经营现金流
FLGT
RICK
| Q4 25 | $-78.1M | — | ||
| Q3 25 | $11.1M | $13.7M | ||
| Q2 25 | $-30.2M | $13.8M | ||
| Q1 25 | $-4.4M | $8.5M | ||
| Q4 24 | $25.0M | $13.3M | ||
| Q3 24 | $-15.5M | $15.7M | ||
| Q2 24 | $4.3M | $15.8M | ||
| Q1 24 | $7.3M | $10.8M |
自由现金流
FLGT
RICK
| Q4 25 | $-83.1M | — | ||
| Q3 25 | $5.1M | $11.5M | ||
| Q2 25 | $-37.0M | $10.1M | ||
| Q1 25 | $-9.1M | $5.7M | ||
| Q4 24 | $21.2M | $7.6M | ||
| Q3 24 | $-35.0M | $10.3M | ||
| Q2 24 | $-8.7M | $9.3M | ||
| Q1 24 | $3.2M | $3.2M |
自由现金流率
FLGT
RICK
| Q4 25 | -99.7% | — | ||
| Q3 25 | 6.0% | 16.2% | ||
| Q2 25 | -45.2% | 14.2% | ||
| Q1 25 | -12.5% | 8.6% | ||
| Q4 24 | 27.9% | 10.6% | ||
| Q3 24 | -48.8% | 14.0% | ||
| Q2 24 | -12.2% | 12.3% | ||
| Q1 24 | 5.0% | 4.4% |
资本支出强度
FLGT
RICK
| Q4 25 | 6.0% | — | ||
| Q3 25 | 7.2% | 3.2% | ||
| Q2 25 | 8.3% | 5.2% | ||
| Q1 25 | 6.4% | 4.3% | ||
| Q4 24 | 5.0% | 8.0% | ||
| Q3 24 | 27.2% | 7.3% | ||
| Q2 24 | 18.2% | 8.4% | ||
| Q1 24 | 6.3% | 10.6% |
现金转化率
FLGT
RICK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLGT
| Precision Diagnostics | $48.3M | 58% |
| Anatomic Pathology | $27.0M | 32% |
| Biopharma Services | $7.8M | 9% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |